Find all the latest information in myelodysplastic syndromes, arranged by subtypes and mutations.
Progress in immunotherapy for hematologic malignancies
Immunotherapy has long been part of the armamentarium of therapies for hematologic malignancies. One of the first applications of immunotherapy...
Targeted next-generation sequencing: A comprehensive genetic profiling tool to simultaneously detect copy number variants and somatic mutations in myeloid malignancies
Next-generation sequencing (NGS)...
DRSS: A new disease risk stratification system for hematologic malignancies
The success of allogeneic hematopoietic stem cell transplantation (allo-HSCT) is largely dependent upon disease type and...
NCCN COVID-19 vaccination recommendations for patients with hematologic malignancies
Patients with cancer are at high risk of COVID-19-associated complications and, accordingly, the preliminary...
Editorial theme | Immune dysregulation and genetic mutations associated with MDS pathogenesis
The pathogenesis of myelodysplastic syndromes (MDS) is heterogeneous, involving inflammation, cytokines,...
Eprenetapopt with azacitidine for TP53-mutant MDS/AML: Results from two ongoing clinical trials
Patients with TP53-mutant myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) experience...
Outcomes of patients with CMML treated with hypomethylating agents
Hypomethylating agents (HMAs) currently remain the only approved drugs for the management of chronic myelomonocytic leukemia (CMML),...
Lenalidomide and epoetin alfa for the treatment of patients with low-risk, non-del(5q) MDS
While not all cases of myelodysplastic syndromes (MDS) require treatment, the development of symptomatic...
MDS precursor conditions
Clonal cytopenia of undetermined significance
Clonal hematopoiesis of indeterminate potential
BCR–ABL1-negative atypical chronic myeloid leukemia
Chronic myelomonocytic leukemia
MDS/MPN with ring sideroblasts and thrombocytosis
MDS with excess blasts
MDS with isolated del(5q)
MDS with multilineage dysplasia
MDS with ring sideroblasts
MDS with single-lineage dysplasia
Therapy-related myeloid neoplasms